PREVYMIS 240 mg Tablets


Tablet
scheduling status
S4
registration number
54/20.2.8/0429
What PREVYMIS 240 mg Tablets contains
Letermovir.
other ingredients
Tablet core: microcrystalline cellulose (E460); croscarmellose sodium (E468); povidone (E1201); colloidal anhydrous silica (E551) and magnesium stearate (E470b). Film-coating: lactose monohydrate; hypromellose (E464); titanium dioxide (E171); triacetin (E1518); iron oxide yellow (E172) and carnauba wax (E903).
Therapeutic classification
Antivirals for systemic use, direct acting antivirals, ATC code: J05AX18.
© 2026 SAHPRA. ALL RIGHTS RESERVED